Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Goodwill (2016 - 2019)

Ironwood Pharmaceuticals' Goodwill history spans 4 years, with the latest figure at $785000.0 for Q4 2019.

  • For Q4 2019, Goodwill changed 0.0% year-over-year to $785000.0; the TTM value through Dec 2019 reached $785000.0, changed 0.0%, while the annual FY2019 figure was $785000.0, 0.0% changed from the prior year.
  • Goodwill for Q4 2019 was $785000.0 at Ironwood Pharmaceuticals, roughly flat from $785000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $785000.0 in Q4 2016 and bottomed at $649000.0 in Q2 2016.
  • The 4-year median for Goodwill is $785000.0 (2016), against an average of $764076.9.
  • The largest YoY upside for Goodwill was 20.96% in 2017 against a maximum downside of 0.0% in 2017.
  • A 4-year view of Goodwill shows it stood at $785000.0 in 2016, then changed by 0.0% to $785000.0 in 2017, then changed by 0.0% to $785000.0 in 2018, then changed by 0.0% to $785000.0 in 2019.
  • Per Business Quant, the three most recent readings for IRWD's Goodwill are $785000.0 (Q4 2019), $785000.0 (Q3 2019), and $785000.0 (Q2 2019).